How long is too long: A retrospective study evaluating the impact of the duration of noninvasive oxygenation support strategies (high flow nasal cannula & BiPAP) on mortality in invasive mechanically ventilated patients with COVID-19.
Aditya KasarabadaKimberly BarkerTheresa GanoeLindsay ClevengerCristina ViscoJessica GibsonRahim KarimiNegar NaderiBrian LamMaria StepanovaLinda HenryChristopher S KingMehul DesaiPublished in: PloS one (2023)
Time spent on noninvasive oxygenation support [as defined by high flow nasal cannula (HFNC) and BiPAP] prior to IMV increased mortality risk. Research for the generalizability of our findings to other respiratory failure patient populations is needed.
Keyphrases
- respiratory failure
- extracorporeal membrane oxygenation
- mechanical ventilation
- acute respiratory distress syndrome
- chronic rhinosinusitis
- intensive care unit
- blood flow
- case report
- cardiovascular events
- risk factors
- type diabetes
- cardiovascular disease
- coronary artery disease
- genetic diversity
- positive airway pressure